Effects of Acupuncture Based on the Meridians Method in the treatment of Anterior Shoulder Pain (Tenosynovitis of Long Head of Biceps Brachii): A Randomized Controlled Trial

注册号:

Registration number:

ITMCTR1900002477

最近更新日期:

Date of Last Refreshed on:

2019-07-18

注册时间:

Date of Registration:

2019-07-18

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

循经取穴针刺治疗肩前痛(肱二头肌长头肌腱鞘炎)的临床研究

Public title:

Effects of Acupuncture Based on the Meridians Method in the treatment of Anterior Shoulder Pain (Tenosynovitis of Long Head of Biceps Brachii): A Randomized Controlled Trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于“体表-体表”联系的循经针刺效应的临床评价及其机制

Scientific title:

Clinical Assessment of Effects of Acupuncture at Acupoints located on Meridians in terms of the connection between different body parts and the Mechanism

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

国家重点研发计划,基于经脉“体表-体表”联系的循经针刺效应的临床评价及其机制,编号2018YFC1704606

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900024583 ; ChiMCTR1900002477

申请注册联系人:

李欢

研究负责人:

乔海法

Applicant:

Li Huan

Study leader:

Qiao Haifa

申请注册联系人电话:

Applicant telephone:

+86 18740597832

研究负责人电话:

Study leader's telephone:

+86 18220046518

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1025783115@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1805355963@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

陕西省西咸新区西咸大道

研究负责人通讯地址:

陕西省西咸新区西咸大道

Applicant address:

Shiji Avenue, Xi'an-Xianyang New Ecomic Zone, Shaanxi, China

Study leader's address:

Shiji Avenue, Xi'an-Xianyang New Ecomic Zone, Shaanxi, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陕西中医药大学

Applicant's institution:

Shaanxi University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

SZFYIEC-PJ-2019年第[14]号

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

陕西中医药大学附属医院伦理委员会

Name of the ethic committee:

IEC of The Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2019/7/3 0:00:00

伦理委员会联系人:

吉娜

Contact Name of the ethic committee:

Ji Na

伦理委员会联系地址:

陕西省咸阳市渭阳西路副2号

Contact Address of the ethic committee:

2 West Weiyang Road, Xianyang, Shaanxi, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 029-33377941

伦理委员会联系人邮箱:

Contact email of the ethic committee:

szfyllwyh@163.com

研究实施负责(组长)单位:

陕西中医药大学

Primary sponsor:

Shaanxi University of Chinese Medicine

研究实施负责(组长)单位地址:

陕西省西咸新区西咸大道

Primary sponsor's address:

Shiji Avenue, Xi'an-Xianyang New Ecomic Zone, Shaanxi, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西省

市(区县):

咸阳市

Country:

China

Province:

Shaanxi

City:

Xianyang

单位(医院):

陕西中医药大学

具体地址:

陕西省西咸新区西咸大道

Institution
hospital:

Shaanxi University of Chinese Medicine

Address:

Shiji Avenue, Xi'an-Xianyang New Ecomic Zone, Shaanxi, China

经费或物资来源:

国家重点研发计划,基于经脉“体表-体表”联系的循经针刺效应的临床评价及其机制,编号2018YFC1704606

Source(s) of funding:

National Key R&D Program: Clinical Assessment of Effects of Acupuncture at Acupoints located on Meridians in terms of the connection between different body parts and the Mechanism, No. 2018YFC1704606

研究疾病:

肩前痛(肱二头肌长头肌腱鞘炎)

研究疾病代码:

Target disease:

Anterior Shoulder Pain ( Tenosynovitis of Long Head of Biceps Brachii)

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

采用多中心、随机、对照的临床 RCT 研究方法,从疗效验证的角度,证实循肺经取穴针刺治疗肩前痛(肱二头肌长头肌腱鞘炎)的临床疗效,并在此基础上采用多模态神经影像技术探讨循肺经取穴治疗肩前痛(肱二头肌长头肌腱鞘炎)的部分中枢机制,以验证肺经与经过的肩前部联系的相对特异性。

Objectives of Study:

Firstly, to demonstrate the effect of acupuncture at acupoints along Lung meridian on anterior shoulder pain(tenosynovitis of long head of biceps brachii), multi-center randomized clinical study will be carried out. Secondly, the mechanism will be explored through multimodal neuroimaging. Therefore, the specific relationship between Lung meridian and anterior shoulder will be addressed.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合诊断肱二头肌长头肌腱鞘炎的标准。 (2)成年男性或女性,年龄18-64岁。 (3)初诊视觉模拟量表(VAS)评分大于4分小于10分(范围为0-10分)。 (4)愿意签署知情同意书。 注:同时符合以上4项的患者,方可纳入本项研究。

Inclusion criteria

1. meet the diagnostic criteria of tenosynovitis of long head of biceps brachii; 2. Male and female aged 18-64 years; 3. Visual Analogue Scale (VAS) score between 4-10 (Range 0-10) for initial visit; 4. volunteered to join the test, and sign " informed consent " persons;Patients who meet.

排除标准:

(1)影像学检查显示有骨结核、肿瘤、重度骨质疏松的病例。 (2)妊娠期和哺乳期女性。 (3)合并有严重内科疾病。 (4)非肱二头肌长头腱鞘炎等其他原因所导致的肩痛。 (5)有局部皮肤破损或严重皮肤病影响手法操作。 (6)无法进行正常交流者。 (7)近3个月内接受过其它保守治疗或手术治疗。 (8)正在参加其他临床试验者。 注:凡符合上述任何一条的患者,均予以排除。

Exclusion criteria:

1. diagnosed as bone tuberculosis, tumors and severe osteoporosis by imaging examination ; 2. pregnant and lactating women; 3. complicated with severe medical diseases; 4. anterior shoulder pain due to non-tenosynovitis of long head of biceps brachii; 5. lesions of skin ( such as damage, burns, and so on ) where acupuncture will be applied; 6. incapacitated or unable to communicate normally; 7. received acupuncture for upper limb pain in the past month; 8. received other conservative treatments or cervical surgery in the past three months; 9. join other clinical trials.

研究实施时间:

Study execute time:

From 2019-08-01

To      2021-07-31

征募观察对象时间:

Recruiting time:

From 2019-08-01

To      2021-07-31

干预措施:

Interventions:

组别:

肺经穴组

样本量:

23

Group:

Lung Meridian Group

Sample size:

干预措施:

压痛点与列缺穴或尺泽穴给予电针,未电针的列缺穴或尺泽穴给予手法行针。

干预措施代码:

Intervention:

Electroacupuncture is applied on the most sensitive tenderness point and LU 7 (Lieque) or LU5 (Chize ); LU 7 or LU5 without electroacupuncture is manipulated manually.

Intervention code:

组别:

心经穴组

样本量:

23

Group:

Heart Meridian Group

Sample size:

干预措施:

压痛点与灵道穴或少海穴给予电针,未电针的灵道穴或少海穴给予手法行针。

干预措施代码:

Intervention:

Electroacupuncture is applied on the most sensitive tenderness point and HT4 (Lingdao) or HT3 (Shaohai ); HT4 or HT3 without electroacupuncture is manipulated manually.

Intervention code:

样本总量 Total sample size : 46

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

陕西省

市(区县):

西安市

Country:

China

Province:

Shaanxi

City:

Xi'an

单位(医院):

西安市中医医院

单位级别:

三级甲等医院

Institution/hospital:

Xi’an Hospital of TCM

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

浙江省

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江中医药大学

单位级别:

大学

Institution/hospital:

Zhejiang Chinese Medical University

Level of the institution:

University

国家:

中国

省(直辖市):

陕西省

市(区县):

咸阳市

Country:

China

Province:

Shaanxi

City:

Xianyang

单位(医院):

陕西中医药大学附属医院

单位级别:

三级甲等医院

Institution/hospital:

The Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

VAS评分

指标类型:

主要指标

Outcome:

VAS score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

SF-36量表及CMS评分

Measure time point of outcome:

Measure method:

SF-36 scale and CMS

指标中文名:

情绪状态评估

指标类型:

次要指标

Outcome:

the Assessing emotions scale

Type:

Secondary indicator

测量时间点:

测量方法:

SAS和SDS自评量表

Measure time point of outcome:

Measure method:

SAS and SDS

指标中文名:

超声变化

指标类型:

次要指标

Outcome:

Musculoskeletal ultrasonography

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

针刺副作用

指标类型:

次要指标

Outcome:

Side-effects

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肩关节活动度

指标类型:

次要指标

Outcome:

Range of motion (ROM) of shoulder

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肌肉评定

指标类型:

次要指标

Outcome:

Muscular assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

MRI变化

指标类型:

次要指标

Outcome:

MRI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 16
Min age years
最大 64
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

委托西安康博瑞生命科学技术有限责任公司,使用中央随机系统,采用配对设计方法。研究者将根据受试者的疼痛程度、年龄、性别等情况进行配对,再将受试者随机分配到两组中,受试者和研究者都无法事先知道和选择治疗方法。

Randomization Procedure (please state who generates the random number sequence and by what method):

Xi'an Kangborui Life Science and Technology Co., Ltd. is authorized to randomize the groups with pair design through the Central Randomization System. The researchers pair subjects according to the pain level, age and gender, and randomized them to two groups. Both the researchers and the subjects do not

盲法:

Open label

Blinding:

Open label

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过学术报告、论文、专著、陕西中医药大学医学科研中心数据库及科技部指定的平台公开数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

By academic reports, papers, monographs, medical research center database of Shaanxi University of Chinese Medicine and platform authorized by Ministry of Science and Technology of China

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF表采集数据,建立数据库

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Collect data via CRF to establish database.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above